Company Filing History:

33 out of 4,442

Eli Lilly and Company

Years Active: 1986-2007

Loading Chart...

38 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 7229987 - Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes (2007-06-12),

2. 7160909 - [object Object] (2007-01-09),

3. 7132456 - MCH receptor antagonists (2006-11-07),

4. 7109231 - Cyclohept[b]indole derivatives (2006-09-19),

5. 6992100 - [object Object] (2006-01-31),

6. 6974831 - sPLA2 inhibitors (2005-12-13),

7. 6930123 - sPLA2 inhibitors (2005-08-16),

8. 6916840 - Spla2 inhibitors (2005-07-12),

9. 6872743 - sPLA2 inhibitors (2005-03-29),

10. 6730694 - sPLA2 inhibitors (2004-05-04),

11. 6713645 - Substituted tricyclics (2004-03-30),

12. 6713505 - spla2 inhibitors (2004-03-30),

13. 6472405 - Glycoprotein IIB/IIIA antagonists (2002-10-29),

14. 6448269 - Glycoprotein IIb/IIIa antagonists (2002-09-10),

15. 6391908 - Oxime amide indole type sPLA2 inhibitors (2002-05-21),

Title: The Inventive Journey of John Michael Morin, Jr.

Introduction:

John Michael Morin, Jr., a prolific inventor based in Brownsburg, IN (US), has made significant strides in the field of pharmaceutical innovations. With an impressive portfolio of 38 patents, his contributions have been instrumental in tackling diseases such as obesity and diabetes.

Latest Patents:

Among his latest patents is a groundbreaking invention focusing on multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes. This compound, along with its derivatives, holds promise in alleviating symptoms associated with these prevalent health conditions. Additionally, Morin, Jr. has introduced a novel class of tricyclic compounds for inhibiting sPLAmediated release of fatty acids, targeting Inflammatory Diseases like septic shock.

Career Highlights:

Morin, Jr. has garnered experience and expertise through his tenure at esteemed companies such as Eli Lilly and Company and Medivir AB. His innovative approach and dedication to research have paved the way for impactful pharmaceutical solutions in the industry.

Collaborations:

Throughout his career, Morin, Jr. has collaborated with accomplished professionals in the field, including Michael Dean Kinnick and Daniel Jon Sall. These collaborations have enriched his inventive journey and have led to the development of cutting-edge solutions for complex medical challenges.

Conclusion:

In conclusion, John Michael Morin, Jr. stands as a beacon of innovation in the realm of pharmaceutical inventions. His relentless pursuit of novel compounds and therapies underscores his commitment to advancing healthcare and addressing critical diseases affecting millions worldwide.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.